BioTime

BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments

BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments

Yahoo/BusinessWire

High But Well-Managed Risk, This Company Is One To Watch Out For

High But Well-Managed Risk, This Company Is One To Watch Out For

Seeking Alpha

BioTime

Companies That Can Mend The Biotech Market: Stephen Brozak

Companies That Can Mend The Biotech Market: Stephen Brozak

Seeking Alpha

2 Stem Cell Research Pioneers And Where They Are Today

2 Stem Cell Research Pioneers And Where They Are Today

Seeking Alpha

Is This Biotech Fishing for a Higher Bid?

Is This Biotech Fishing for a Higher Bid?

Motley Fool

1 Stem-Cell Spinout You Must Watch

1 Stem-Cell Spinout You Must Watch

Motley Fool

BioTime

BioTime makes offer for Geron stem cell assets

BioTime makes offer for Geron stem cell assets

Yahoo/AP

6 Biotech Stocks That Could Be In For A Short Squeeze

6 Biotech Stocks That Could Be In For A Short Squeeze

Seeking Alpha

Stem Cell Hype Has Yet To Breed Profits

Stem Cell Hype Has Yet To Breed Profits

Seeking Alpha